AntibioticsINJECTIONGeneric
PERMAPEN
PENICILLIN G BENZATHINE
Standard Dose
600,000 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PERMAPEN is listed in Drugs@FDA under application 060014 (NDA).
Marketing status: Discontinued Active ingredient PENICILLIN G BENZATHINE Form and strength INJECTABLE;INJECTION - 600,000 UNITS/ML Sponsor CASPER PHARMA LLC Submission history Latest submission status date: 2000-02-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview PERMAPEN is listed in Drugs@FDA under application 060014 (NDA). Marketing status: Discontinued Active ingredient PENICILLIN G BENZATHINE Form and strength INJECTABLE;INJECTION - 600,000 UNITS/ML Sponsor CASPER PHARMA LLC Submission history Latest submission status date: 2000-02-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: N/A
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.